Ariston, Irwin M.
HRN: 26-05-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/17/2024
10/24/2024
IV
600MG
Q8
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes